Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5

PHASE3CompletedINTERVENTIONAL
Enrollment

452

Participants

Timeline

Start Date

January 24, 2024

Primary Completion Date

September 22, 2025

Study Completion Date

September 22, 2025

Conditions
Ischemic Stroke, Acute
Interventions
DRUG

Tenecteplase

Intravenous tenecteplase (0.25mg/kg, maximum 25mg, administered as a bolus within 5-10 seconds) within 24 hours ± thrombectomy at treating clinician's discretion

DRUG

Best Practice (which may include intravenous Alteplase)

Intravenous alteplase (0.9mg/kg) within 4.5 hours from stroke onset or standard care (no lysis) ± thrombectomy at treating clinician's discretion

Trial Locations (59)

100070

Beijing Tian Tan Hospital, Capital Medical University, Beijing

Unknown

Taihe County Traditional Chinese Medicine Hospital, Fuyang

Lixin County People's Hospital, Haozhou

First People's Hospital of Tianshui, Tianshui

Guangdong Second Provincial General Hospital, Guangzhou

Heyuan People's Hospital, Heyuan

Huazhou People's Hospital, Huazhou

Shaoguan Qujiang District People's Hospital, Shaoguan

The Second Affiliated Hospital of Guizhou Medical University, Guiyang

The Second People's Hospital of Guiyang, Guiyang

Qiandongnanzhou People's Hospital, Qiandongnan

Haikou People's Hospital, Haikou

Affiliated Hospital of Hebei University, Baoding

Qiu County People's Hospital, Handan

The Second Hospital of Qinhuangdao, Qinhuangdao

Tangshan Guye Traditional Chinese Medicine Hospital, Tangshan

Qinghe County People's Hospital, Xingtai

The 2nd Affiliated Hospital of Harbin Medical University, Harbin

The First Affiliated Hospital of Harbin Medical University, Harbin

Hongxinglong Hospital of Beidahuang Group, Shuangyashan

Huaxian People's Hospital of Henan, Anyang

Jiaozuo Coal Industry Central Hospital, Jiaozuo

The First People Hospital of Lingbao, Lingbao

Liuyang Jili Hospital, Liuyang

Nanshi Hospital of Nanyang, Nanyang

Nanle County People's Hospital, Puyang

Nanle Zhongxing Hospital, Puyang

Puyang Oilfield General Hospital, Puyang

Guangshan County People's Hospital, Xinyang

Xi County People's Hospital, Xinyang

Taikang Xian People's Hospital, Zhoukou

People's Hospital of Queshan, Zhumadian

Zhumadian Traditional Chinese Medicine Hospital, Zhumadian

Chenzhou First People's Hospital, Chenzhou

The Fourth People's Hospital of Chenzhou, Chenzhou

Hengyang Central Hospital, Hengyang

Keshketeng Banner Chinese-Mongolian Hospital, Keshketeng Banner

Tongliao People's Hospital, Tongliao

Jiujiang First People's Hospital, Jiujiang

Jilin Electric Power Hospital, Changchun

Siping City Central People's Hospital, Siping

Liuhe County People's Hospital, Tonghua

The First Affiliated Hospital of Jinzhou Medical University, Jinzhou

The People's Hospital of Liaoning Province, Shenyang

The Second People's Hospital of Dongying, Dongying

Gaomi People's Hospital, Gaomi

Laizhou City People's Hospital, Laizhou

Linyi People's Hospital, Linyi

Qingdao Municipal Hospital, Qingdao

The Second Affiliated Hospital of Shandong First Medical University, Taian

The Affiliated Hospital of Shandong Second Medical University, Weifang

Weifang People's Hospital, Weifang

Weihai Central Hospital, Weihai

Yantai Taochun Central Hospital, Yantai

Zaozhuang Municipal Hospital, Zaozhuang

Linfen Central Hospital, Linfen

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

Ningbo Beilun District People's Hospital, Ningbo

Beijing Daxing District People's Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06196320 - Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events-5 | Biotech Hunter | Biotech Hunter